Abbott Rapid Diagnostics
Part of the group
18 companies in 11 countries
Board
1 director, last change in January 2026Director
since 01-01-2026
term without a fixed end
listed in the 2025 annual accounts, filed on 02-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 27-11-2019
Mandates through the years
17 names, the dashed line is todayDirector
Director
Director
Statutory auditor
Statutory auditor
Statutory auditor
Manager
Manager
Manager
Manager
Manager
Manager
Manager
Manager
Manager
Statutory auditor
Manager
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Director, since before 31-12-2025
-
- Director, from 20-10-2017 to 01-01-2026
-
- Director, from 01-08-2009 to 01-06-2023
-
- Statutory auditor, appointed by deed of 11-04-2022, no longer listed in the 2025 annual accounts
-
- Statutory auditor, appointed by deed of 12-02-2019, until 11-04-2022
-
- Statutory auditor, appointed by deed of 20-08-2014, until 26-11-2018
-
- Manager, appointed by deed of 06-08-2018, until 26-10-2018
-
- Manager, appointed by deed of 31-01-2018, until 06-08-2018
-
- Manager, appointed by deed of 31-01-2018, no longer listed in the 2025 annual accounts
-
- Manager, appointed by deed of 27-11-2014, until 31-01-2018
-
- Manager, appointed by deed of 21-09-2015, ended, last mentioned on 21-09-2015
- Manager, until 31-01-2018
-
- Manager, appointed by deed of 27-11-2014, ended, last mentioned on 27-11-2014
- Manager, until 31-12-2014
-
- Manager, until 01-09-2014
-
- Manager, appointed by deed of 04-10-2012, until 01-09-2014
-
- Manager, until 01-09-2014
-
- Statutory auditor, appointed by deed of 10-12-2012, until 20-08-2014
-
- Manager, until 04-10-2012
Control
Parent
Equity €2.10bn
Profit €369.8m in 2025 (loss €5.4m in 2024)
Checked score
Source: own accounts 2025
100%
This company
Abbott Rapid Diagnostics
Equity €7.1m
Profit €301,639 in 2025
Further up the chain US consolidated
Capital
- Contribution
- €30,232.99
- Shares
- 2,494
- Contribution per share
- €12.12
- Equity per share
- €2,830 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themSource: shareholder structure in its own accounts, parent in its own accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 27-11-2019 (in Dutch)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Natuurlijke personen of rechtspersonen, algemene vergadering die benoemt”deed of 27-11-2019 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “"repertorium 2022/2295 Blad(en): 3 Verzending(en): 0 Geregistreerd op het registratiekantoor KANTOOR RECHTSZEKERHEID BRUSSEL 5 op…”deed of 20-02-2023 (in Dutch)